Alibaba (09988) has unified its large model brand to Qian Wen.
Alibaba (09988) announced that its AI's collective name and core brand have been unified as "Qianwen".
Alibaba (09988) announced that its AI's overall name and core brand have been unified as Qwen, and the Qwen large model covers basic large models and professional domain models. The Qwen App is its flagship AI application on the consumer end. It is reported that this move is to avoid confusion caused by the previous multiple names such as Qwen, Tongyi Qwen, and Qwen, after the unified name, the Chinese name of Alibaba's large model brand is "Qwen large model", and the English name is "Qwen", and "Tongyi Laboratory" is the organizational name of Alibaba Group's AI institution.
Alibaba stated that on New Year's Eve this year, it released Qwen 3.5 open source, and subsequently released multiple medium and small Qwen 3.5 models. With strong performance and high efficiency, Qwen 3.5 ranked in the top 4 on the global open-source large model list of Hugging Face, becoming the most popular large model in the global AI community currently. During the Spring Festival, users placed "one-click orders" nearly 200 million times on the Qwen App. QuestMobile data shows that during the Spring Festival, Qwen's DAU reached 73.52 million, leading the domestic AI application market with a 940% increase, and Qwen has become a national-level AI assistant.
Related Articles

On March 2, Lens Technology (06613) spent 33.2082 million yuan to repurchase 981,800 A shares.

Beijing Foyou Pharma (601089.SH) has received the approval notice for the listing application of alamode chemical raw materials.

Beijing Hotgen Biotech Co.,Ltd(688068.SH): Innovative drug AA001 monoclonal antibody Ib phase clinical study completed the first dose of Alzheimer's disease subjects.
On March 2, Lens Technology (06613) spent 33.2082 million yuan to repurchase 981,800 A shares.

Beijing Foyou Pharma (601089.SH) has received the approval notice for the listing application of alamode chemical raw materials.

Beijing Hotgen Biotech Co.,Ltd(688068.SH): Innovative drug AA001 monoclonal antibody Ib phase clinical study completed the first dose of Alzheimer's disease subjects.

RECOMMEND





